Pneumocystis Pneumonia Developing during Treatment of Recurrent Renal Cell Cancer with Nivolumab / 대한내과학회지
Korean Journal of Medicine
;
: 571-574, 2018.
Artículo
en Coreano
| WPRIM
| ID: wpr-718858
ABSTRACT
Nivolumab is an immune checkpoint inhibitor approved for the treatment of metastatic cancers. Here, we report the case of a 65-year-old male with recurrent renal cell carcinoma. After six cycles of nivolumab treatment, positron emission tomography/computed tomography (PET/CT) was performed to evaluate the response. PET/CT revealed diffuse ground glass opacities in both lungs. He developed a cough, sputum, chills, and a febrile sense. After bronchoscopic bronchoalveolar lavage, pneumocystis pneumonia was finally diagnosed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pneumocystis
/
Neumonía
/
Neumonía por Pneumocystis
/
Esputo
/
Carcinoma de Células Renales
/
Lavado Broncoalveolar
/
Tos
/
Escalofríos
/
Electrones
/
Tomografía Computarizada por Tomografía de Emisión de Positrones
Límite:
Anciano
/
Humanos
/
Masculino
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS